115 related articles for article (PubMed ID: 2156252)
1. [Progesterone receptors in breast cancer. Comparison of immunohistochemical with biochemical receptor analysis. Relation between hormone receptor content and growth fraction (Ki-67)].
Ronay G; Sponsel N; Merkle E; Tulusan AH
Pathologe; 1990 Jan; 11(1):4-9. PubMed ID: 2156252
[No Abstract] [Full Text] [Related]
2. [Ductal carcinoma in situ: steroid receptors and proliferation kinetics].
Ronay G; Sponsel N; Tulusan AH
Pathologe; 1990 Nov; 11(6):327-31. PubMed ID: 1963219
[No Abstract] [Full Text] [Related]
3. [Cell receptors and proliferation markers in breast cancer].
Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
[No Abstract] [Full Text] [Related]
4. [The immunohistochemical growth fraction (Ki-67) of breast cancers: relations to tumor spread, tumor morphology and receptor testing].
Weikel W; Beck T; Rosenthal H; Herzog R
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):277-82. PubMed ID: 2566552
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical detection of progesterone receptors in breast cancer. Comparison of antibodies mPRI and PR-ICA].
Weikel W; Rosenthal H; Beck T; Mitze M
Pathologe; 1990 Mar; 11(2):85-8. PubMed ID: 2184428
[No Abstract] [Full Text] [Related]
6. [Tumor properties of primary tumors and local recurrence of breast cancer].
Torsten U; Opri F; Moreno-Richter I; Weitzel HK
Zentralbl Gynakol; 1993; 115(3):99-104. PubMed ID: 8385409
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases].
Fleige B; Pickartz H; Stein H
Pathologe; 1989 Jan; 10(1):12-5. PubMed ID: 2646629
[No Abstract] [Full Text] [Related]
8. [Immunohistochemical detection of estrogen and progesterone receptors in breast cancer using monoclonal antibodies: comparison with biochemical receptor analysis].
Scharl A; Vierbuchen M; Würz H
Pathologe; 1989 Jan; 10(1):31-8. PubMed ID: 2646630
[No Abstract] [Full Text] [Related]
9. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
Remmele W; Schicketanz KH
Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
[No Abstract] [Full Text] [Related]
10. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
11. [Hormone receptor status in breast cancer in comparison with histologic tumor type].
Kasch R; Meissner J; Haack D; Neumann S
Zentralbl Gynakol; 1987; 109(24):1493-6. PubMed ID: 2831683
[TBL] [Abstract][Full Text] [Related]
12. [Significance of the proliferative activity of breast cancer for prognosis and therapy].
Pickartz H
Z Arztl Fortbild (Jena); 1991 Oct; 85(20):993-4. PubMed ID: 1776291
[No Abstract] [Full Text] [Related]
13. [Leukocytic cell infiltrates in breast cancer. Studies using monoclonal antibodies].
Gokel JM; Göttlinger HG; Schleiffenbaum B; Rieber P; Riethmüller G
Verh Dtsch Ges Pathol; 1985; 69():258-63. PubMed ID: 3006380
[No Abstract] [Full Text] [Related]
14. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
[TBL] [Abstract][Full Text] [Related]
15. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of the prognosis of breast cancer. Determination of the growth fraction using monoclonal antibody Ki-67].
Lellé RJ
Fortschr Med; 1989 Jun; 107(17):380-1. PubMed ID: 2663680
[No Abstract] [Full Text] [Related]
17. [Use of polymerase chain reaction (PCR) as an additional diagnostic method in gynecologic oncology].
Czerwenka KF; Zeillinger R; Kury F; Manavi M; Speiser P; Peschke M; Steinhart U; Hosmann JW; Kubista E
Gynakol Rundsch; 1991; 31 Suppl 2():378-9. PubMed ID: 1686430
[No Abstract] [Full Text] [Related]
18. [Immunohistochemical detection of estrogen and progesterone receptors in paraffin sections].
Snijders M; Theunissen P; Debets-Te Baerts M; Koudstaal J
Pathologe; 1990 Jul; 11(4):236-9. PubMed ID: 2204912
[No Abstract] [Full Text] [Related]
19. [Thermolabile characteristics of steroid hormone receptors in breast cancer].
Merkle E; Bähr I; Tulusan AH; Lang N
Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):182-5. PubMed ID: 2055391
[TBL] [Abstract][Full Text] [Related]
20. Expression of normal and tumor-associated antigens in human breast carcinoma.
Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
